City of Hope Comprehensive Cancer Center
Duarte, California, 91010-3000, United States
NCT Number: NCT00900835
RATIONALE: Collecting information over time about patients' and health care providers' understanding of pain and fatigue and providing education about pain and fatigue management may improve quality of life.
PURPOSE: This clinical trial is studying pain and fatigue management in patients with breast cancer, prostate cancer, colon cancer, or lung cancer.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Duarte, California, 91010-3000, United States
OBJECTIVES:
OUTLINE: Patients are stratified according to cancer diagnosis (breast vs prostate vs colon vs lung), pain level (< 4 vs ≥ 4 on pain scale), and fatigue level (< 4 vs ≥ 4 on fatigue scale). Patients are assigned to 1 of 3 groups.
After completion of study intervention, patients are followed at 1 and 3 months.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
DISEASE CHARACTERISTICS:
PATIENT CHARACTERISTICS:
PRIOR CONCURRENT THERAPY:
City of Hope Medical Center
Other
Reducing Barriers to Pain and Fatigue Management
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00303914
Breast Cancer, Breast Diseases
Chicago, Illinois, United States
View Trial DetailsNCT00335491
Adnexal Diseases, Bladder Cancer
Salt Lake City, Utah, United States
View Trial DetailsNCT00963911
Breast Cancer, Breast Diseases
Bordeaux, France
View Trial DetailsNCT00036790
Blast Crisis, Blood Protein Disorders
Pittsburgh, Pennsylvania, United States
View Trial Details